top of page

Germany may avoid a scenario where marijuana legalization is delayed as advocates have worried in recent weeks, with top cabinets official pledging to make certain changes to the legislation passed by parliament in hopes of averting a mediation committee referral.

While the Bundestag passed the cannabis legalization bill last month, there’s been an expectation that the Bundesrat, a body known as the Federal Council that represents individual German states, would vote to recommend the committee referral during a meeting scheduled for Friday, which would push back the implementation by six months, from April to October.

To prevent that delay, Health Minister Karl Lauterbach, who has for months been the government’s lead on the cannabis plan, has proposed a “protocol declaration” to the Federal Council ahead of the vote that aims to address members’ outstanding concerns about issues such as youth prevention, reduced cultivation canopy sizes and zoning requirements for social clubs that could eventually distribute marijuana to adults.

State Health Minister Petra Köpping of the Social Democratic Party (SPD) said on Tuesday that Lauterbach “promised” him that he would enact the revisions and signaled the move may avoid a situation where the Bundesrat votes to refer the bill to a mediation committee, Legal Tribune Online reported.

Am Freitag berät der #Bundesrat zum #Cannabisgesetz. Es handelt sich um ein Einspruchsgesetz – drei Ausschüsse empfehlen dem Plenum, den #Vermittlungsausschuss anzurufen. Mehr dazu in #BundesratKOMPAKThttps://t.co/rjsJaVxmnP

— Bundesrat (@bundesrat) March 20, 2024


That’s especially notable given that Köpping led the amendment, adopted in the Health Committee earlier this month, to delay the implementation of legalization.

While the protocol declaration that Lauterbach is putting forward is not legally binding, the commitment is giving advocates hope that the current timeline will hold.

There’s also an agreement to give state regulators additional flexibility with respect to monitoring cannabis social clubs, RND reported.

“We are in very constructive discussions,” Kirsten Kappert-Gonthe of the Green Party said, according to a translation.

Es macht sich mehr und mehr Zuversicht breit, dass am Freitag nicht der VA zum #Cannabis|G angerufen wird+der "überfällige Paradigmenwechsel" eingeläutet wird. "Wir sind in sehr konstruktiven Gesprächen", so @KirstenKappert. Habe ich auch gehört…#Weedmobhttps://t.co/x3XcY5QOoz

— Hasso Suliak🇪🇺🇺🇦 (@HassoSuliak) March 20, 2024


Meanwhile, Transport Minister Volker Wissing of the Free Democratic Party (FDP) is calling for another change to the law by relaxing the zero-tolerance THC limit for impaired driving, Spiegel reported.

The Bundesrat previously tried to block the proposed reform in September but ultimately failed.

Last month’s floor vote in the Bundestag came weeks after leaders of the coalition government announced that they’d reached a final agreement on the legalization bill, resolving outstanding concerns, primarily from the SPD.

A final Bundestag vote on the legalization bill that was initially planned in December was ultimately called off amid concerns from SPD leaders.

Lawmakers had already delayed their first debate on the legislation, which was ultimately held in October, ostensibly due to the conflict in Israel and Palestine. They also pushed back a vote scheduled for November as supporters worked on improvements to the bill.

At a meeting in December, the health minister took questions from members, some of whom oppose legalization. At several points, he pushed back against lawmakers who suggested that legalization would send the wrong message to youth and lead to increased underage consumption, saying their arguments “misrepresented” the legislation.

Lawmakers also previously made a raft of adjustments to the bill, mostly designed to loosen restrictions that faced opposition from advocates and supporters in the Bundestag. They included increasing home possession maximums and removing the possibility of jail time for possessing slightly more than the allowable limit.

The legislators further agreed to stagger the implementation of the reform, planning to make possession and home cultivation legal for adults beginning in April. Social clubs where members could obtain marijuana would open in July.

Officials are eventually planning to introduce a complementary second measure that would establish pilot programs for commercial sales in cities throughout the country. That legislation is expected to be unveiled after its submitted to the European Commission for review.

Marijuana Moment is tracking more than 1,400 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

While Germany’s Federal Cabinet approved the initial framework for a legalization measure in late 2022, the government also said it wanted to get signoff from the EU to ensure that enacting the reform wouldn’t put them in violation of their international obligations.

The framework was the product of months of review and negotiations within the German administration and the traffic light coalition government. Officials took a first step toward legalization in 2022, kicking off a series of hearings meant to help inform legislation to end prohibition in the country.

Government officials from multiple countries, including the U.S., also met in Germany last November to discuss international marijuana policy issues as the host nation works to enact legalization.

A group of German lawmakers, as well as Narcotics Drugs Commissioner Burkhard Blienert, separately visited the U.S. and toured California cannabis businesses in 2022 to inform their country’s approach to legalization.

The visit came after top officials from Germany, Luxembourg, Malta and the Netherlands held a first-of-its-kind meeting to discuss plans and challenges associated with recreational marijuana legalization.

Leaders of the coalition government said in 2021 that they had reached an agreement to end cannabis prohibition and enact regulations for a legal industry, and they first previewed certain details of that plan last year.

A novel international survey that was released in 2022 found majority support for legalization in several key European countries, including Germany.

Meanwhile, the United Nations’s (UN) drug control body recently reiterated that it considers legalizing marijuana for non-medical or scientific purposes a violation of international treaties, though it also said it appreciates that Germany’s government scaled back its cannabis plan ahead of the recent vote.

21 State Attorneys General Push Congress To Regulate Intoxicating Hemp Products

 
 
 

Germany’s parliament has officially approved a bill to legalize marijuana nationwide.

Two days after the cannabis legislation was considered by eight committees of the Bundestag, the full body voted 407-226 on final passage on Friday.

The bill—which will make possession and home cultivation legal and authorize social clubs that can distribute marijuana to members—now heads to the Bundesrat, a separate legislative chamber that represents German states, though its members cannot stop the reform from being enacted.

While supporters have said legalization would take effect in April if it’s enacted, there are new questions about that timeline. The Bundesrat may move to refer the legislation to a mediation committee to address criminal justice-related implications of the law, which could mean several months of additional discussion.

The floor vote comes weeks after leaders of Germany’s so-called traffic light coalition government announced that they’d reached a final agreement on the legalization bill, resolving outstanding concerns, primarily from the Social Democratic Party (SPD).

Health Minister Karl Lauterbach, who has for months been the government’s lead on the cannabis plan, said ahead of the floor vote that the country is “fundamentally changing our cannabis control policy in order to combat the black market.”

Hier meine Rede für die Legalisierung #Cannabis. Die bisherige Verbotspolitik ist gescheitert. Mehr konsumierende Kinder, mehr Schwarzmarkt, toxische Cannabisprodukte, steigende Kriminalität. So geht es nicht weiter. Aufklärung statt Verbote, ohne Schwarzmarkt sind bessere Lösung https://t.co/E1I0bKuxR7

— Prof. Karl Lauterbach (@Karl_Lauterbach) February 23, 2024


“The second goal is better protection for children and young people,” he said, pointing to high youth use rates under the current law and saying that the legalization proposal is an “urgently needed modernization of our cannabis policy.”

Kirsten Kappert-Gonthe of the Green Party called the current system of criminalization “absurd,” saying that prohibition has created a situation where “children and young people in our country can easily get cannabis on every corner” due to the lack of regulations that the legal market, in contrast, will institute.

Ein großer Erfolg! Das #CanG wurde im Bundestag verabschiedet. Wir beenden Prohibition und #Kriminalisierung und machen den Weg frei für Jugend-und Gesundheitsschutz. Nach diesem langen Prozess freue ich mich sehr über das Erreichte und danke allen für ihren Einsatz.🥦

— Kirsten Kappert-Gonther (@KirstenKappert) February 23, 2024


Kristine Lütke, a lawmaker with the Free Democratic Party (FDP), said legalization “strengthens individual freedom in Germany.”

“Today a chapter comes to an end and a new one begins,” she said. “We are talking about a historical turning point. We are voting for a paradigm shift in German cannabis policy.”

Wir sorgen für mehr Kinder-, Jugend- und Gesundheitsschutz + schaffen eine erhebliche Verbesserung bei Medizinalcannabis. Die Justiz wird erheblich entlastet und wir verbessern die Prävention.

— Kristine Lütke MdB (@kristine_lutke) February 23, 2024


Under legalization, “consumers know where the cannabis comes from, how much they have, how much it contains and know that it is not mixed with substances that are harmful to health—much more dangerous drugs,” Lütke said.

Members of the center-right CDU/CSU alliance strongly opposed the reform. Lawmaker Simone Bourchardt, for example, argued that legalization “would be an additional burden” on the country’s “strained health system,” pointing to marijuana’s “impairment of cognitive abilities.”

Ahead of the final vote, lawmakers rejected opposition motions to block legalization from CDU/CSU and Alternative for Germany.

Germans support legalization, but only by a narrow margin, according to a new poll. Forty-seven percent back the reform, compared to 42 percent who are against, with another 11 percent undecided, the survey from YouGov found.

A final vote on the legalization bill that was initially planned in December was ultimately called off amid concerns from SPD leaders.

Lawmakers had already delayed their first debate on the legislation, which was ultimately held in October, ostensibly due to the conflict in Israel and Palestine. They also pushed back a vote scheduled for November as supporters worked on improvements to the bill.

At a meeting in December, the health minister took questions from members, some of whom oppose legalization. At several points, he pushed back against lawmakers who suggested that legalization would send the wrong message to youth and lead to increased underage consumption, saying their arguments “misrepresented” the legislation.

Lawmakers also recently made a raft of adjustments to the bill, mostly designed to loosen restrictions that faced opposition from advocates and supporters in the Bundestag. They included increasing home possession maximums and removing the possibility of jail time for possessing slightly more than the allowable limit.

The legislators further agreed to stagger the implementation of the reform, planning to make possession and home cultivation legal for adults beginning in April. Social clubs where members could obtain marijuana would open in July.

Officials are eventually planning to introduce a complementary second measure that would establish pilot programs for commercial sales in cities throughout the country. That legislation is expected to be unveiled after its submitted to the European Commission for review.

For what it’s worth, the Bundesrat representing German states previously tried to block the proposed reform in September but ultimately failed.

Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Lawmakers in the Bundestag recently held a hearing in the Health Committee, at which opponents criticized some elements of the proposal.

The body also heard a competing policy proposal from The Union, a political alliance of the Christian Democratic Union and Christian Social Union (CDU/CSU), that would not legalize marijuana but instead “improve health protection and strengthen education, prevention and research,” Kappert-Gonther said at the time.

The health minister responded to early criticism of the bill from medical and law enforcement groups by emphasizing that the reform would be coupled with a “major campaign” to educate the public about the risks of using cannabis.

While Germany’s Federal Cabinet approved the initial framework for a legalization measure in late 2022, the government also said it wanted to get signoff from the EU to ensure that enacting the reform wouldn’t put them in violation of their international obligations.

The framework was the product of months of review and negotiations within the German administration and the traffic light coalition government. Officials took a first step toward legalization in 2022, kicking off a series of hearings meant to help inform legislation to end prohibition in the country.

Government officials from multiple countries, including the U.S., also met in Germany last November to discuss international marijuana policy issues as the host nation works to enact legalization.

A group of German lawmakers, as well as Narcotics Drugs Commissioner Burkhard Blienert, separately visited the U.S. and toured California cannabis businesses in 2022 to inform their country’s approach to legalization.

The visit came after top officials from Germany, Luxembourg, Malta and the Netherlands held a first-of-its-kind meeting to discuss plans and challenges associated with recreational marijuana legalization.

Leaders of the coalition government said in 2021 that they had reached an agreement to end cannabis prohibition and enact regulations for a legal industry, and they first previewed certain details of that plan last year.

A novel international survey that was released in 2022 found majority support for legalization in several key European countries, including Germany.

Biden Pushed To Reschedule Marijuana By Veterans And Law Enforcement Groups—Including One That Has DEA Head As A Member

 
 
 

The Drug Enforcement Administration (DEA) is facing criticism over its decision to commemorate President Richard Nixon’s drug war legacy in a social media post that coincided with the beginning of Black History Month.

DEA’s Throwback Thursday (or TBT) post on X featured a picture of Nixon receiving a “certificate of special honor” from the International Narcotic Enforcement Officers’ Association in December 1970 “in recognition of the outstanding loyalty and contribution to support narcotic law enforcement.”

#TBT On Dec. 14, 1970, at the White House, the International Narcotic Enforcement Officers’ Association presented President Nixon with a “certificate of special honor" in recognition of the outstanding loyalty and contribution to support narcotic law enforcement. #DEAHistorypic.twitter.com/xC5Omns20q

— DEA HQ (@DEAHQ) February 1, 2024


Advocates blasted the homage as tone-deaf, memorializing a president whose own domestic policy advisor would later disclose that his boss promoted punitive drug laws in large part to target his political “enemies,” namely “the anti-war left and Black people.”

https://t.co/cG6W5FcEt4pic.twitter.com/vo4Ykk1BFl

— Justin Strekal (@justinstrekal) February 2, 2024


DEA didn’t necessarily endorse or provide commentary beyond sharing the moment in history—but the TBT post quickly incited criticism given the timing in connection to Black History Month.

It was also about six months after the photo of Nixon was taken that he’d infamously declare a war on drugs, fueling a mass incarceration movement that would have racially disparate impacts lasting generations into the modern day.

As the Drug Policy Alliance (DPA) pointed out, 1970 also marked the year that Nixon signed the Controlled Substances Act (CSA), codifying broad drug criminalization in a way that has long empowered DEA and is actively being reviewed by the agency as it weighs a marijuana rescheduling recommendation from the U.S. Department of Health and Human Services (HHS).

#TBT Nixon signed the fear- and stigma-based Controlled Substances Act in 1970, declared the disastrous “war on drugs” in 1971, & ignored calls to decriminalize marijuana in 1972. @DEAHQ’s history leaves all that out. Our Drug War History page doesn’t: https://t.co/MuJ5QatKgzhttps://t.co/RSnEf0fwIt

— Drug Policy Alliance (@DrugPolicyOrg) February 1, 2024


“This is the agency that we are supposed to trust to objectively decide cannabis final schedule?” Kaliko Castille, who recently ended his tenure as president of the Minority Cannabis Business Association (MCBA), said. “Posting drug war propaganda to kick off the first day of Black History Month?”

This is the agency that we are supposed to trust to objectively decide #cannabis final schedule?

Posting drug war propaganda to kick off the first day of Black History Month? https://t.co/mxs02mFx7P

— Kaliko Castille (@WizKaliko) February 2, 2024


Cat Packer, director of drug markets and legal regulation at DPA, shared the sentiment.

“On the first day of Black History Month 2024 the Biden Administration’s DEA is celebrating President Nixon—this is the same agency responsible for marijuana scheduling,” she said.

On the first day of Black History Month 2024 the Biden Administration’s DEA is celebrating President Nixon— this is the same agency responsible for marijuana scheduling. 🤡 https://t.co/FHUkD9F76Gpic.twitter.com/cIDnURpahs

— Cat Packer (@cat_packer) February 1, 2024


Here’s how others reacted to DEA’s Nixon post: 

DEA starting Black History Month with a ‘throwback Thursday’ that should remind everyone they were founded by racists with the intention of systemically oppressing and harming people of color in the US and around the world https://t.co/vuO3fAd3THhttps://t.co/FACrb0BRKkpic.twitter.com/oE0xWPtU8n

— Ryan Marino, MD (@RyanMarino) February 1, 2024


Literally just got done with a training where we cited John Ehrlichman admitting that the WoD specifically targeted Black people and how this has led to mass incarceration & overdose deaths.

To honor #BlackHistoryMonth is to give an accurate history & to support harm reduction. https://t.co/rVeqcFJ7kk

— Lighthouse Learning Collective (@HRC_Lighthouse) February 2, 2024


White House: Well, it's Black History Month. What do folks have planned?

DEA: Glazing on Nixon.

WH: I'm sorry…what?

DEA: What better way to celebrate Black people by honoring the guy who weaponized drug use to incarcerate millions of Black folks?

WH: *Sigh* https://t.co/FNwM87gXsu

— Coalition for Syringe Access (@SyringeAccess) February 2, 2024


Wow. This is the guy you chose to honor on the first day of #BlackHistoryMonth?🙄 https://t.co/zwuBr20JWQ

— Sanho Tree (@SanhoTree) February 1, 2024


The unpopularity of the drug war and DEA’s role in that crusade hasn’t stopped the agency from celebrating its history.

Last year, for example, it touted its 50-year anniversary, marking a half century of enforcing criminalization laws that have failed to fulfill the mission to eradicate drugs at the same time that nearly half of the country has legalized marijuana and psychedelics reform is also booming.

DEA’s own museum is rife with subtle acknowledgements that the agency has failed to win the drug war. In 2022, the museum even publicly recognized the fact that racially discriminatory drug laws are partly responsible for the agency’s own founding.

In any case, the agency is now actively completing a review into cannabis scheduling that could either depart from, or reinforce, its reputation with the public that’s invited criticism. While HHS has advised DEA to move marijuana from Schedule I to Schedule III of the CSA, the law enforcement agency has emphasized that it reserves “final authority” in the matter, so it remains to be seen.

South Carolina Senators Fall Short Of Supermajority Vote To Advance Medical Marijuana Legalization Bill

 
 
 

Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page